<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: drug manufacturers</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Renaissance in new drugs for rare diseases</title>
   	 <description>Once famously described as &quot;orphan diseases, too small to be noticed, too small to be funded&quot; in the Hollywood drama Lorenzo's Oil, rare diseases are getting unprecedented attention today among drug manufacturers, who are ramping up research efforts and marketing new medicines that promise fuller lives for children and other patients with these heartbreaking conditions.</description>
	  <link>http://medicalxpress.com/news/2013-05-renaissance-drugs-rare-diseases.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 13 May 2013 08:36:10 EST</pubDate>
	 <guid isPermaLink="false">news287652957</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/1-renaissancei.jpg" width="90" height="90" />
</item>
<item>
     <title>Potential diabetes breakthrough: Researchers discover new hormone spurring beta cell production</title>
   	 <description>Researchers at the Harvard Stem Cell Institute (HSCI) have discovered a hormone that holds promise for a dramatically more effective treatment of type 2 diabetes, a metabolic illness afflicting an estimated 26 million Americans. The researchers believe that the hormone might also have a role in treating type 1, or juvenile, diabetes.</description>
	  <link>http://medicalxpress.com/news/2013-04-potential-diabetes-breakthrough-hormone-spurring.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 25 Apr 2013 12:00:08 EST</pubDate>
	 <guid isPermaLink="false">news286108507</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/potentialdia.jpg" width="90" height="90" />
</item>
<item>
     <title>FDA requires lower doses for sleep medications (Update)</title>
   	 <description>(HealthDay)—The U.S. Food and Drug Administration announced Thursday that it is asking manufacturers of sleep medications containing zolpidem—including Ambien—to lower the recommended doses and to provide more safety information to patients.</description>
	  <link>http://medicalxpress.com/news/2013-01-fda-requires-doses-medications.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 10 Jan 2013 11:50:01 EST</pubDate>
	 <guid isPermaLink="false">news277040406</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/fdalowerambi.jpg" width="90" height="90" />
</item>
<item>
     <title>Problems at second US firm tied to meningitis outbreak</title>
   	 <description>US federal health inspectors said Monday they have uncovered serious problems at a second Massachusetts pharmacy run by some of the same people whose tainted drugs caused a deadly meningitis outbreak.</description>
	  <link>http://medicalxpress.com/news/2012-11-problems-firm-tied-meningitis-outbreak.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 12 Nov 2012 18:10:01 EST</pubDate>
	 <guid isPermaLink="false">news271965626</guid>
	 
</item>
<item>
     <title>The perils of delivering anti-malarial drugs through private sector examined</title>
   	 <description>(Medical Xpress)—Getting high-quality anti-malarial drugs to people in places like Zanzibar and Mozambique is a tricky business.</description>
	  <link>http://medicalxpress.com/news/2012-11-perils-anti-malarial-drugs-private-sector.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 09 Nov 2012 06:26:52 EST</pubDate>
	 <guid isPermaLink="false">news271664801</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/theperilsofd.jpg" width="90" height="90" />
</item>
<item>
     <title>US meningitis death toll rises to 30, officials say</title>
   	 <description>The death toll from a meningitis outbreak linked to tainted drugs rose to 30 as the number of cases climbed to a whopping 419, US health officials said Monday.</description>
	  <link>http://medicalxpress.com/news/2012-11-meningitis-death-toll.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 05 Nov 2012 18:20:40 EST</pubDate>
	 <guid isPermaLink="false">news271362028</guid>
	 
</item>
<item>
     <title>Experts call for increased neonatal inclusion in pediatric drug trials</title>
   	 <description>Clinical drug trials are a vital part of pharmaceutical manufacturers gaining approval for use by the U.S. Food and Drug Administration. A Commentary scheduled for publication in The Journal of Pediatrics assesses the issues surrounding the lack of clinical trials on medications used by children, most notably neonates, and how drug manufacturers and academic researchers could work together to create clinical trials that would benefit this underrepresented population.</description>
	  <link>http://medicalxpress.com/news/2012-10-experts-neonatal-inclusion-pediatric-drug.html</link>
	 <category>Pediatrics</category>
	 <pubDate>Thu, 25 Oct 2012 03:42:04 EST</pubDate>
	 <guid isPermaLink="false">news270355265</guid>
	 
</item>
<item>
     <title>A heavy price for cheaper drugs</title>
   	 <description>You get what you pay for. This maxim is proving true all over again when it comes to steroid injections used to alleviate back pain. Making safe and effective versions of such drugs involves manufacturing steps that aren't trivial. The cost of the medicine has to match the care that goes into creating it and the oversight required to ensure that the standards are maintained.</description>
	  <link>http://medicalxpress.com/news/2012-10-heavy-price-cheaper-drugs.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 23 Oct 2012 13:30:07 EST</pubDate>
	 <guid isPermaLink="false">news270216953</guid>
	 
</item>
<item>
     <title>US meningitis death toll up to 23: CDC</title>
   	 <description>The death toll in the United States from an unprecedented outbreak of fungal meningitis linked to a contaminated drug has climbed to 23 people, health officials said Saturday.</description>
	  <link>http://medicalxpress.com/news/2012-10-meningitis-death-toll-cdc.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sat, 20 Oct 2012 17:23:52 EST</pubDate>
	 <guid isPermaLink="false">news269972622</guid>
	 
</item>
<item>
     <title>US meningitis outbreak death toll rises to 15</title>
   	 <description> The death toll from an unprecedented US meningitis outbreak tied to a tainted steroid jumped to 15 after another person died from a fungal form of the disease, health authorities said Saturday.</description>
	  <link>http://medicalxpress.com/news/2012-10-meningitis-outbreak-death-toll.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sun, 14 Oct 2012 05:55:42 EST</pubDate>
	 <guid isPermaLink="false">news269412935</guid>
	 
</item>
<item>
     <title>Long wait for answers in US tainted drug outbreak</title>
   	 <description> Thousands of Americans who may have been injected with a tainted steroid will have to wait weeks to see if they have been infected with meningitis as investigators seek answers to a widening outbreak.</description>
	  <link>http://medicalxpress.com/news/2012-10-tainted-drug-outbreak.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sat, 13 Oct 2012 05:30:02 EST</pubDate>
	 <guid isPermaLink="false">news269323703</guid>
	 
</item>
<item>
     <title>US tainted drug outbreak rises to 185 cases</title>
   	 <description> The number of people believed to have been sickened by a contaminated drug rose to 185 Friday, but US health officials said the death toll from the rare meningitis outbreak held steady at 14.</description>
	  <link>http://medicalxpress.com/news/2012-10-tainted-drug-outbreak-cases.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 12 Oct 2012 17:15:03 EST</pubDate>
	 <guid isPermaLink="false">news269280898</guid>
	 
</item>
<item>
     <title>Calls for more US oversight after tainted drug outbreak</title>
   	 <description> A deadly meningitis outbreak in the United States blamed on a tainted drug has triggered outrage and calls for tighter regulation of the loosely controlled pharmaceutical compounding industry.</description>
	  <link>http://medicalxpress.com/news/2012-10-oversight-tainted-drug-outbreak.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 11 Oct 2012 17:08:47 EST</pubDate>
	 <guid isPermaLink="false">news269194120</guid>
	 
</item>
<item>
     <title>Tainted drug death toll rises to 14 in US</title>
   	 <description> The death toll from a deadly meningitis outbreak in the United States blamed on a tainted drug rose to 14 Thursday as the number of cases jumped to 172 in 11 states, health officials said.</description>
	  <link>http://medicalxpress.com/news/2012-10-tainted-drug-death-toll.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 11 Oct 2012 16:43:26 EST</pubDate>
	 <guid isPermaLink="false">news269192596</guid>
	 
</item>
<item>
     <title>Mayo Clinic physicians ID reasons for high cost of cancer drugs, prescribe solutions</title>
   	 <description>A virtual monopoly held by some drug manufacturers in part because of the way treatment protocols work is among the reasons cancer drugs cost so much in the United States, according to a commentary by two Mayo Clinic physicians in the October issue of the journal Mayo Clinic Proceedings. Value-based pricing is one potential solution, they write.</description>
	  <link>http://medicalxpress.com/news/2012-10-mayo-clinic-physicians-id-high.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 01 Oct 2012 02:52:04 EST</pubDate>
	 <guid isPermaLink="false">news268278685</guid>
	 
</item>
<item>
     <title>Bangladesh doctors urge Viagra production halt</title>
   	 <description> Bangladeshi doctors Wednesday asked the government to halt permits for Viagra to be mass produced for the domestic market, fearing it could lead to the anti-impotence drug becoming available over the counter.</description>
	  <link>http://medicalxpress.com/news/2012-09-bangladesh-doctors-urge-viagra-production.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 26 Sep 2012 11:02:46 EST</pubDate>
	 <guid isPermaLink="false">news267876161</guid>
	 
</item>
<item>
     <title>Breast stem-cell research: Receptor teamwork is required and a new pathway may be involved</title>
   	 <description>Breast-cancer researchers at the University of Wisconsin-Madison have found that two related receptors in a robust signaling pathway must work together as a team to maintain normal activity in mammary stem cells.</description>
	  <link>http://medicalxpress.com/news/2012-05-breast-stem-cell-receptor-teamwork-required.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 30 May 2012 13:40:01 EST</pubDate>
	 <guid isPermaLink="false">news257602172</guid>
	 
</item>
<item>
     <title>New federal disclosure law may have little impact on drugs prescribed</title>
   	 <description>A Colorado School of Public Health researcher has found that laws designed to illuminate financial links between doctors and pharmaceutical companies have little or no effect on what drugs physicians prescribe.</description>
	  <link>http://medicalxpress.com/news/2012-05-federal-disclosure-law-impact-drugs.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 29 May 2012 12:39:00 EST</pubDate>
	 <guid isPermaLink="false">news257513930</guid>
	 
</item>
<item>
     <title>Indian expert panel to probe drugs regulator</title>
   	 <description> India's Health Ministry said Friday it had set up an expert panel to review the operations of its drug regulatory agency, accused of colluding with pharmaceutical firms to approve drugs without trials.</description>
	  <link>http://medicalxpress.com/news/2012-05-indian-expert-panel-probe-drugs.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 11 May 2012 09:41:02 EST</pubDate>
	 <guid isPermaLink="false">news255948057</guid>
	 
</item>
<item>
     <title>India probes charges of violations by drugs regulator</title>
   	 <description> India's Health Ministry said Thursday it was examining charges that the government's top drug regulatory agency had colluded with pharmaceutical firms to approve drugs without proper clinical trials.</description>
	  <link>http://medicalxpress.com/news/2012-05-india-probes-violations-drugs.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 10 May 2012 08:50:01 EST</pubDate>
	 <guid isPermaLink="false">news255856758</guid>
	 
</item>
<item>
     <title>3Qs: Analyzing why sudden drug shortages occur</title>
   	 <description>Drug manufacturers and the Food and Drug Administration (FDA) scrambled earlier this month to address a sudden shortage of methotrexate, a 60-year-old drug that treats children with severe cases of leukemia and sarcoma. Graham Jones, the chair of the chemistry and chemical biology department in the College of Science, said the problem is likely to continue as fewer pharmaceutical companies produce drugs with slim profit margins and a small patient base.</description>
	  <link>http://medicalxpress.com/news/2012-02-3qs-sudden-drug-shortages.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 28 Feb 2012 07:13:20 EST</pubDate>
	 <guid isPermaLink="false">news249635584</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/3qsanalyzing.jpg" width="90" height="90" />
</item>
<item>
     <title>India's global pharmacy role threatened by EU pact</title>
   	 <description>(AP) --  Efforts by India and the European Union to strengthen trade are threatening India's ability to deliver lifesaving medicines to the world's poorest, analysts say as the two sides push through protracted negotiations on a free-trade pact.</description>
	  <link>http://medicalxpress.com/news/2012-02-india-global-pharmacy-role-threatened.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 10 Feb 2012 05:30:02 EST</pubDate>
	 <guid isPermaLink="false">news248074058</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/indiasglobal.jpg" width="90" height="90" />
</item>
<item>
     <title>GE Healthcare settles with $30 million in overpaying case</title>
   	 <description> GE Healthcare, a branch of General Electric, has paid the government a settlement of $30 million plus interest for improper billing by a company it bought in 2004, officials said Thursday.</description>
	  <link>http://medicalxpress.com/news/2011-12-ge-healthcare-million-overpaying-case.html</link>
	 <category>Health</category>
	 <pubDate>Fri, 30 Dec 2011 03:40:07 EST</pubDate>
	 <guid isPermaLink="false">news244438796</guid>
	 
</item>
<item>
     <title>Novartis fights patent rejection in Indian court</title>
   	 <description>(AP) --  In a case that could affect India's role as drug provider to the developing world, the Supreme Court began hearing arguments Tuesday over whether the government had the right to deny a patent to Swiss drugmaker Novartis AG for its lifesaving cancer treatment Gleevec.</description>
	  <link>http://medicalxpress.com/news/2011-09-novartis-patent-indian-court.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 06 Sep 2011 10:22:55 EST</pubDate>
	 <guid isPermaLink="false">news234523359</guid>
	 
</item>
<item>
     <title>Neuroscientists' discovery could bring relief to epilepsy sufferers</title>
   	 <description>Researchers at the University of California, Riverside have made a discovery in the lab that could help drug manufacturers develop new antiepileptic drugs and explore novel strategies for treating seizures associated with epilepsy &amp;#150; a disease affecting about two million Americans.</description>
	  <link>http://medicalxpress.com/news/2011-06-neuroscientists-discovery-relief-epilepsy.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 21 Jun 2011 12:57:45 EST</pubDate>
	 <guid isPermaLink="false">news227879848</guid>
	 
</item>
<item>
     <title>Medical students have substantial exposure to pharmaceutical industry marketing</title>
   	 <description>Medical students in the United States are frequently exposed to pharmaceutical marketing, even in their preclinical years, and the extent of their contact with industry is associated with positive attitudes about marketing and skepticism towards any negative implications. These findings from research led by Kirsten Austad and Aaron S. Kesselheim from the Harvard Medical School in Boston, USA, published in this week's PLoS Medicine, suggest that strategies to educate students about interactions with the pharmaceutical industry should directly address widely-held misconceptions about the effects of marketing.</description>
	  <link>http://medicalxpress.com/news/2011-05-medical-students-substantial-exposure-pharmaceutical.html</link>
	 <category>Other</category>
	 <pubDate>Tue, 24 May 2011 17:48:06 EST</pubDate>
	 <guid isPermaLink="false">news225478065</guid>
	 
</item>


</channel>
</rss>
